<DOC>
	<DOCNO>NCT02648906</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Choline alfoscerate Donepezil cognitive improvement patient cerebrovascular injury Alzheimer patient</brief_summary>
	<brief_title>A Clinical Trial Evaluation Choline Alfoscerate Donepezil Cognitive Improvements Patients With Cerebrovascular Injury Alzheimer Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 . 56~90 male female 2 . MiniMental State Evaluation ( MMSE ) 24 12 3 . Score â‰¥ 2 New Rating Scale Agerelated White Matter Changes ( ARWMC ) , rating scale cerebral ischemic injury evaluate MRI 4 . Score 0.5 , 1 , 2 CDR 5. presence least two follow vascular risk factor : hypertension , diabetes , obesity , ischemic heart disease , dyslipidemia , hyperhomocysteinemia , smoking , previous cerebrovascular event familiar history cardiocerebrovascular disease . 6. donepezil 10mg 3 month ago , dose change clinical trial 7 . A subject provide write informed consent participate study cooperative regard compliance study relate constraint 1 . Subjects allergic sensitive Investigational Product applicable ingredient 2. subject take medication 1 month screen 1 ) Cholinesterase Inhibitors 2 ) NMDA receptor antagonists 3 ) blood circulation supplement 4 ) AcetylLCarnitines 5 ) Nicergoline 6 ) Subject take another medication affect result primary outcome 3. subject ca n't evaluate ADAScog , MMSE , NPI , ADL , CDR , Attention Questionnaire Scale etc . 4 . Asthma , COPD 5 . Decompensated heart disease 6 . Chronic renal failure chronic liver disease 7 . Malignant tumor 8 . Subject cant ' follow 12 month Investigational drug take . 9 Subjects pregnant , lactating plan pregnant clinical period female child bear year use available contraceptive method 10 . Subject take clinical licensed medication another clinical trial within 30 day prior screen period 11.Other subject deem appropriate clinical study discretion investigator</criteria>
	<gender>All</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>